July 11, 2023
In conclusion, our study conducted within real-world clinical settings revealed a noteworthy association between the use of GLP-1 RAs, including Liraglutide and Semaglutide, and a heightened risk of psychiatric outcomes, encompassing depression, anxiety, and suicidal behaviour
This suggests potential applications for retatrutide in preventing or reversing liver disease associated with obesity [R]
Researchers discovered exendin-4, a peptide structurally similar to human GLP-1 but far more resistant to enzymatic breakdown
Strategies to mitigate muscle loss Muscle talks to your gut during exercise: Physical activity triggers muscle release of IL-6 and other signals that actually boost GLP-1 production in the intestines, creating a natural feedback loop that supports metabolism
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice